Europe has taken the lead in the development and commercialization of biosimilar medicines because they have the same effectiveness as biological medicines and can be used in treatment of serious diseases such as cancer, at a much lower cost. In 2006, the development of biosimilar medicines began, a technology that caused a revolution in the […]
Although its personalized medicine`s products aren’t in the market yet, the test for early colon cancer detection, ‘ColoFast’, might be available the next year in the European Union and the United States of America. How do Amadix’s advances benefit cancer patients? Find out below. Amadix is a Spanish biotech company founded in 2010 that develops […]
Medmesafe is a digital platform dedicated to the analysis and genetic counseling. In fact, this is the first online platform of predictive and personalized medicine to offer this type of service, with which you can meet your genetic predisposition to develop different types of diseases. That a person knows the state of their genes allows her to […]
On the International Day of Action against Migraine we present the latest advances arising within the therapy field of this neurological condition so widespread and with severe disabling effects. A medical revolution is brewing around this pathology, emerging the foundations of a medicine through food, and not focused only on the use of drugs. Medical nutrition represents […]
Founded in 2007 by Kevin Lustig, Christopher Petersen and Andrew Martin, Scientist.com has become one of the world’s leading marketplaces for outsourced research. In this online marketplace researchers can find more than 3,500+ research tools and services, connect with more than 17,500+ global research suppliers and get access to most of the later cutting-edge technologies […]
Discover how the spanish biotech GENOMICA has become a world leader in the field of molecular diagnostics and genetic identification. since its foundation in 1990 and capitalized to 100% by its parent company PharmaMar, which is currently the Spanish multinational global leader in the development and commercialization of antitumor drugs of marine origin, grows from its birth for […]
Advanced therapies based on cellular therapies, which use stem cells and biodegradable devices or prostheses for growth and application of the same, constitute a new way to treat a variety of diseases, including heart disease called ischemic. Ischaemic heart diseases, such as heart attacks and angina pectoris, are caused by the development of arteriosclerosis in […]
The biological drugs and their biosimilar drugs constitute a paradigm of pharmacological innovation by allowing to alter the course of a disease by acting on an aspect or very specific mechanism of a specific cell, organ or system. For this reason, they have managed to improve the expectations and the quality of life for patients […]
The use of the antimalarial drug artemisinin, a sesquiterpene lactone extracted from the glandular trichomes from the plant Artemisia annua, was described for the first time in the Handbook of prescriptions for emergencies, edited by the middle of the 4th century by Ge Hong, Chinese scholar who devoted a large part of his studies to the discovery of physical immortality. […]
The case of the R+D+i Artennua project, developed by the union of forces between the Catalan biotech company Sequentia Biotech and the Canary Islands Institute of Agricultural Research (ICIA), brings together all the potential to generate natural treatments that prevent the advance of the global malaria and other diseases of high prevalence as different types of cancer, multiple sclerosis, […]